BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1958902)

  • 1. Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors.
    Martin PJ
    Bone Marrow Transplant; 1991 Sep; 8(3):217-23. PubMed ID: 1958902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.
    Goulmy E; Schipper R; Pool J; Blokland E; Falkenburg JH; Vossen J; Gratwohl A; Vogelsang GB; van Houwelingen HC; van Rood JJ
    N Engl J Med; 1996 Feb; 334(5):281-5. PubMed ID: 8532022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
    Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
    Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
    Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion.
    Ash RC; Horowitz MM; Gale RP; van Bekkum DW; Casper JT; Gordon-Smith EC; Henslee PJ; Kolb HJ; Lowenberg B; Masaoka T
    Bone Marrow Transplant; 1991 Jun; 7(6):443-52. PubMed ID: 1873591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histocompatibility and bone marrow transplantation (BMT).
    Richter KV
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):445-50. PubMed ID: 2480287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
    Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
    Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of recipient-specific alloreactivity: is GVHD predictable?
    Theobald M; Bunjes D; Nierle T; Arnold R; Heimpel H
    Bone Marrow Transplant; 1993; 12 Suppl 3():S18-23. PubMed ID: 8124251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of donor and recipient gender disparities on fatal graft-vs.-host disease in a mouse model for major histocompatibility complex-matched unrelated-donor bone marrow transplantation.
    OKunewick JP; Kociban DL; Machen LL; Buffo MJ
    Exp Hematol; 1993 Nov; 21(12):1570-6. PubMed ID: 8405238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation.
    Loiseau P; Espérou H; Busson M; Sghiri R; Tamouza R; Hilarius M; Raffoux C; Devergie A; Ribaud P; Socié G; Gluckman E; Charron D
    Bone Marrow Transplant; 2002 Oct; 30(8):497-502. PubMed ID: 12379888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular techniques for typing unrelated marrow donors: potential impact of molecular typing disparity on donor selection.
    Baxter-Lowe LA
    Bone Marrow Transplant; 1994; 14 Suppl 4():S42-50. PubMed ID: 7728125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marrow transplants from HLA matched unrelated donors: an NMDP update and the Seattle experience.
    Anasetti C; Howe C; Petersdorf EW; Martin PJ; Hansen JA
    Bone Marrow Transplant; 1994 Jun; 13(6):693-5. PubMed ID: 7920294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation using unrelated and family related donors: the impact of HLA-C disparity.
    Nagler A; Brautbar C; Slavin S; Bishara A
    Bone Marrow Transplant; 1996 Nov; 18(5):891-7. PubMed ID: 8932842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?
    Ringdén O; Schaffer M; Le Blanc K; Persson U; Hauzenberger D; Abedi MR; Olerup O; Ljungman P; Remberger M
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):128-34. PubMed ID: 14750078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are human platelet alloantigens (HPA) minor transplantation antigens in clinical bone marrow transplantation?
    Rozman P; Karas M; Kosir A; Labar B; Madrigal A; Middleton D; Navarrete C; Oudshoorn M; Schennach H; Vitek A; Bohinjec M;
    Bone Marrow Transplant; 2003 Mar; 31(6):497-506. PubMed ID: 12665847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recipient mHag-HA1 disparity and aGVHD in thalassemic-transplanted patients.
    Nesci S; Buffi O; Iliescu A; Andreani M; Lucarelli G
    Bone Marrow Transplant; 2003 Apr; 31(7):575-8. PubMed ID: 12692624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.